小方制药：12月19日召开董事会会议

Group 1 - The company, Xiaofang Pharmaceutical, announced the convening of its second board meeting on December 19, 2025, to discuss adjustments to its 2025 restricted stock incentive plan [1] - For the year 2024, the company's revenue composition is projected to be 99.93% from pharmaceutical preparations and 0.07% from other businesses [1] - As of the report, Xiaofang Pharmaceutical has a market capitalization of 4.6 billion yuan [1]